CULT Food Sciences continues to place itself at the forefront of the lab-grown meat analogues and alternatives field. Their recent appointment of pharmacologist Paul Burridge to their advisory board should really give them an edge on innovation.
Burridge is the principal of the Burridge Lab at Northwestern University, which currently researches the use of induced pluripotent stemcells (iPSC) in the use of cultivated meats.
Burridge’s insights into this bleeding edge technology should really give $CULT and their subsidiaries the upper hand in developing meat analogues and pushing them to market.
$CULT has an impressive portfolio of companies ranging from producers of consumer and high-end meat products, to synthetic honey and plant based egg products.
With a focus on environmental impact and sustainability, $CULT is set up to be an industry-leading ethical platform for investors to gain exposure to the synthetic foods market.
I’m really excited for CULT to IPO and will be waiting patiently for them to do so.